NLRP3 and COVID-19: In the context of COVID-19, NLRP3 inflammasome activation can drive prolonged and excessive inflammation, contributing to cytokine storm in severe cases and potentially leading to long-term immune dysregulation (Liang et al., 2024; Pan et al., 2021; Vora et al., 2021).